As of 2026-07-15, the EV/EBITDA ratio of Cell Impact AB (publ) (CI.ST) is -1.18. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CI.ST's latest enterprise value is 59.87 mil SEK. CI.ST's TTM EBITDA according to its financial statements is -50.92 mil SEK. Dividing these 2 quantities gives us the above CI.ST EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 11.0x - 17.4x | 13.7x |
| Forward P/E multiples | 12.6x - 14.8x | 13.8x |
| Fair Price | (0.99) - (1.16) | (1.08) |
| Upside | -1436.9% - -1659.5% | -1549.7% |
| Date | EV/EBITDA |
| 2026-07-08 | -1.12 |
| 2026-07-07 | -1.14 |
| 2026-07-06 | -1.14 |
| 2026-07-03 | -1.21 |
| 2026-07-02 | -1.23 |
| 2026-07-01 | -1.24 |
| 2026-06-30 | -1.24 |
| 2026-06-29 | -1.53 |
| 2026-06-26 | -1.34 |
| 2026-06-25 | -1.56 |
| 2026-06-24 | -1.61 |
| 2026-06-23 | -1.47 |
| 2026-06-22 | -1.17 |
| 2026-06-18 | -1.41 |
| 2026-06-17 | -1.45 |
| 2026-06-16 | -1.87 |
| 2026-06-15 | -1.90 |
| 2026-06-12 | -1.90 |
| 2026-06-11 | -1.91 |
| 2026-06-10 | -1.88 |
| 2026-06-09 | -1.90 |
| 2026-06-08 | -1.86 |
| 2026-06-05 | -1.90 |
| 2026-06-04 | -1.89 |
| 2026-06-03 | -1.95 |
| 2026-06-02 | -2.00 |
| 2026-06-01 | -1.98 |
| 2026-05-29 | -1.98 |
| 2026-05-28 | -2.07 |
| 2026-05-27 | -2.16 |
| 2026-05-26 | -2.12 |
| 2026-05-25 | -2.19 |
| 2026-05-22 | -2.21 |
| 2026-05-21 | -2.20 |
| 2026-05-20 | -2.24 |
| 2026-05-19 | -2.26 |
| 2026-05-18 | -2.25 |
| 2026-05-15 | -2.40 |
| 2026-05-13 | -2.38 |
| 2026-05-12 | -3.11 |
| 2026-05-11 | -3.03 |
| 2026-05-08 | -3.09 |
| 2026-05-07 | -3.06 |
| 2026-05-06 | -2.90 |
| 2026-05-05 | -3.05 |
| 2026-05-04 | -3.38 |
| 2026-04-30 | -3.38 |
| 2026-04-29 | -3.03 |
| 2026-04-28 | -3.03 |
| 2026-04-27 | -3.05 |